Moreover, in patients who were at high risk of heart failure after acute coronary syndrome, sitagliptin exposure was not associated with an increased risk of de novo heart failure [79] or other adverse cardiovascular events [80]
And if the government has taken a step to set drug prices lower, and those lower prices lead to less profitability for PBMs, then thats a good thing, but if the PBMs turn around and then increase prices on patients that are taking these medicines make them less accessible, then thats a bad thing
Patients should be aware of the warning signs of blood clots and seek immediate medical attention if they develop symptoms suggestive of DVT or PE
Research focus: initially explored in obesity and metabolic-syndrome models
Prescription medications like semaglutide and tirzepatide have transformed weight management for millions
Minor stressors that you would normally handle without difficulty suddenly feel overwhelming